A rendering of Amgen's new science and innovation center in Thousand Oaks. (courtesy photo) Thousand Oaks-based Amgen started the new year with excitement by adding to its robust oncology pipeline. Amgen, one of the largest biotech companies in the world, announced its acquisition of Dark Blue Therapeutics, a U.K.-based biotech company specializing in advancing first-in-class,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
